1328 related articles for article (PubMed ID: 21703206)
1. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
[TBL] [Abstract][Full Text] [Related]
3. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.
Pan CQ; Han GR; Jiang HX; Zhao W; Cao MK; Wang CM; Yue X; Wang GJ
Clin Gastroenterol Hepatol; 2012 May; 10(5):520-6. PubMed ID: 22343511
[TBL] [Abstract][Full Text] [Related]
4. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
Jiang HX; Han GR; Wang CM; Ji Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
[TBL] [Abstract][Full Text] [Related]
5. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
6. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
7. [Abstract efficacy of combined vaccine for the prevention of HBV transmission in highly viremic HBeAg+ mothers and the HBV markers' dynamic change of babies in follow-up].
Jiang HX; Han GR; Wang CM; Yue X; Wang GJ
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):818-22. PubMed ID: 22433302
[TBL] [Abstract][Full Text] [Related]
8. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
[TBL] [Abstract][Full Text] [Related]
9. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
10. Telbivudine versus lamivudine in patients with chronic hepatitis B.
Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA;
N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378
[TBL] [Abstract][Full Text] [Related]
11. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
Liaw YF; Gane E; Leung N; Zeuzem S; Wang Y; Lai CL; Heathcote EJ; Manns M; Bzowej N; Niu J; Han SH; Hwang SG; Cakaloglu Y; Tong MJ; Papatheodoridis G; Chen Y; Brown NA; Albanis E; Galil K; Naoumov NV;
Gastroenterology; 2009 Feb; 136(2):486-95. PubMed ID: 19027013
[TBL] [Abstract][Full Text] [Related]
12. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
Sun W; Zhao S; Ma L; Hao A; Zhao B; Zhou L; Li F; Song M
BMC Gastroenterol; 2017 Apr; 17(1):51. PubMed ID: 28407735
[TBL] [Abstract][Full Text] [Related]
13. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy.
Liu M; Cai H; Yi W
J Viral Hepat; 2013 Apr; 20 Suppl 1():65-70. PubMed ID: 23458527
[TBL] [Abstract][Full Text] [Related]
14. On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients.
Cai W; Xie Q; An B; Wang H; Zhou X; Zhao G; Guo Q; Gu R; Bao S
J Clin Virol; 2010 May; 48(1):22-6. PubMed ID: 20233672
[TBL] [Abstract][Full Text] [Related]
15. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants.
Pan CQ; Zou HB; Chen Y; Zhang X; Zhang H; Li J; Duan Z
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1349-55. PubMed ID: 23639606
[TBL] [Abstract][Full Text] [Related]
16. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
17. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
18. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.
Han GR; Jiang HX; Wang CM; Ding Y; Wang GJ; Yue X; Zhou L; Zhao W
J Viral Hepat; 2017 Jun; 24(6):514-521. PubMed ID: 28039902
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
